1B1 — Hc Surgical Specialists Income Statement
0.000.00%
Last trade - 00:00
- SG$39.99m
- SG$37.75m
- SG$19.08m
- 97
- 75
- 21
- 76
2019 May 31st | 2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 18.3 | 16.7 | 23.4 | 19.3 | 19.1 |
Cost of Revenue | |||||
Gross Profit | 16.3 | 14.8 | 20.3 | 16.7 | 16.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 11 | 10.9 | 12.7 | 12.1 | 12.7 |
Operating Profit | 7.27 | 5.78 | 10.7 | 7.23 | 6.34 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 9.44 | 4.82 | 10.3 | 7.75 | 4.05 |
Provision for Income Taxes | |||||
Net Income After Taxes | 8.43 | 4.04 | 8.85 | 6.8 | 2.98 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 7.21 | 3.5 | 8 | 6.38 | 2.92 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7.21 | 3.5 | 8 | 6.38 | 2.92 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.048 | 0.027 | 0.048 | 0.045 | 0.025 |
Dividends per Share |